株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

血管ステントの世界市場:市場考察、機会分析、市場シェア、予測

Global Vascular Stent Market Research Report Insights, Opportunity Analysis, Market Shares and Forecast, 2017 - 2023

発行 Occams Business Research & Consulting Pvt. Ltd. 商品コード 577325
出版日 ページ情報 英文 190 Pages
納期: お問合せ
価格
本日の銀行送金レート: 1USD=109.87円で換算しております。
Back to Top
血管ステントの世界市場:市場考察、機会分析、市場シェア、予測 Global Vascular Stent Market Research Report Insights, Opportunity Analysis, Market Shares and Forecast, 2017 - 2023
出版日: 2017年10月27日 ページ情報: 英文 190 Pages
概要

当レポートでは、血管ステントの世界市場について調査し、市場の概要、タイプ・製品・技術・材料・エンドユーザー・地域別の市場動向、市場規模の推移と予測(過去3年間・今後7年間分)、市場促進・阻害要因および市場機会・課題の分析、競合情勢、主要企業のプロファイルなど、体系的な情報を提供しています。

第1章 イントロダクション

  • エグゼクティブサマリー
  • 推計手法

第2章 市場概要

  • 血管ステントの世界市場:発展と変遷
  • 市場の定義と範囲
  • 産業構造
  • 規制の指針
  • 市場分析
  • 予測分析
  • 戦略分析
    • 投資 vs 導入モデル
    • 全方位的産業分析
    • ファイブフォース分析
    • シーソー分析
    • コンシューマー分析・主な購買基準
  • 競合分析
    • 市場シェアおよび上位企業の分析
  • 戦略提言と総論
    • 地域別の投資機会
    • 新用途における市場機会
    • 最速成長市場の投資機会

第3章 市場の決定要因

  • 促進要因
  • 阻害要因
  • 市場機会
  • 課題

第4章 血管ステントの世界市場:セグメント別

  • 血管ステントの世界市場:タイプ別
    • 薬剤溶出性ステント(DES)
    • 金属ステント(BMS)
    • 生体吸収性ステント(BVS)
  • 血管ステントの世界市場:製品別
    • 冠動脈用ステント
    • 抹消血管用ステント
    • ステントグラフト内挿術(EVAR)用ステント
  • 血管ステントの世界市場:技術別
    • バルーン拡張型ステント
    • 自己拡張型ステント
  • 血管ステントの世界市場:材料別
    • 金属
    • その他
  • 血管ステントの世界市場:エンドユーザー別
    • 病院・心臓疾患センター
    • 外来外科センター

第5章 競合情勢

  • 主な戦略
    • 合併・買収
    • 合弁事業
    • 製品の上市
    • パートナーシップ

第6章 血管ステントの世界市場:地域別

  • 意思決定支援データベース・推計手法
  • 市場セグメントの比較分析
  • 市場機会のマトリクス
  • 地域区分
    • 北米
    • 欧州
    • アジア太平洋
    • その他の地域

第7章 企業プロファイル

  • ABBOTT LABORATORIES
  • B. BRAUN MELSUNGEN AG
  • BIOTRONIK SE & CO. KG
  • BOSTON SCIENTIFIC CORPORATION
  • C.R. BARD, INC.
  • CORDIS CORPORATION
  • ENDOLOGIX, INC.
  • LOMBARD MEDICAL
  • MEDTRONIC PLC
  • MERIL LIFE SCIENCES PVT. LTD.
  • MICROPORT SCIENTIFIC CORPORATION
  • テルモ
  • TRANSLUMINA GMBH
  • VASCULAR CONCEPTS LIMITED
  • W.L. GORE AND ASSOCIATES, INC.
目次
Product Code: HME-8091017

Vascular stents are majorly used in the treatment of vascular diseases such as, atherosclerosis and peripheral artery disease, blood clotting disorders, etc. The global vascular stent market is expected to rise at a CAGR of about 7.5% during the forecast period 2016-2023.Rising prevalence of vascular diseases and growth in geriatric population across the globe majorly contributes to the market growth during forecast period. However, availability of alternative treatment methods for vascular diseases such as drug treatment, product failures and recalls are the factors restraining growth of global vascular stent market during forecast period.

Geographically, North America held the largest market revenue share for the vascular stent market in 2016 followed by Europe and is expected to dominate the market during forecast period. Countries such as United States and Canada contribute to the dominance of North America. Dominance of North America, during the forecast period is witnessed due to rising prevalence of cardio vascular diseases. According to the Centers for Disease Control and Prevention (CDCP), United States, nearly 630,000 Americans die from heart disease each year (1 in every 4 deaths). Furthermore, Asia Pacific is expected to be the fastest growing region for stent market during the forecast period due to growing geriatric population in the region.

The growth in the global vascular stent market is also influenced by the presence of major players such as Microport Scientific Corporation (China), TransluminaGmbh (Germany), W.L. Gore And Associates, Inc. (U.S.), Medtronic Plc (U.S.), Boston Scientific Corporation (U.S), etc. To gain competitive advantage the major players adopt various strategies such as mergers & acquisitions, product launch, strategic partnership, collaboration, joint ventures, etc.

Global vascular stent market report covers segmentation analysis of type, product, and mode of delivery, material and end users. Report further covers segments of type which include drug-eluting stents, bare-metal stents and bioabsorbable stent. Drug-eluting stent held the largest market share in terms of revenue in 2016 and is expected to dominate the type segment during the forecast period. The dominance is witnessed due to numerous advantages of drug-eluting stents over bare-metal stent such as s lower risk of restenosis, etc. Furthermore, Mode of delivery in vascular stent includes balloon expandable stents and self-expanding stents. Balloon expandable stents segment is expected to grow at the highest rate during the forecast period. Fastest growth rate of balloon expandable stents is expected due to increasing regulatory approvals for balloon-expandable stents and its high usage in angioplasty procedures.

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. EXECUTIVE SUMMARY
  • 1.2. ESTIMATION METHODOLOGY

2. MARKET OVERVIEW

  • 2.1. GLOBAL VASCULAR STENT MARKET: EVOLUTION & TRANSITION
  • 2.2. MARKET DEFINITION & SCOPE
  • 2.3. INDUSTRY STRUCTURE
  • 2.4. REGULATORY FRAMEWORK
  • 2.5. TOTAL MARKET ANALYSIS
    • 2.5.1. TOP 5 FINDINGS
    • 2.5.2. TOP 5 OPPORTUNITY MARKETS
    • 2.5.3. TOP 5 COMPANIES
    • 2.5.4. TOP 3 COMPETITIVE STRATEGIES
  • 2.6. ESTIMATION ANALYSIS
  • 2.7. STRATEGIC ANALYSIS
    • 2.7.1. INVESTMENT VS. ADOPTION MODEL
    • 2.7.2. 360-DEGREE INDUSTRY ANALYSIS
    • 2.7.3. PORTERS 5 FORCE MODEL
    • 2.7.4. SEE-SAW ANALYSIS
    • 2.7.5. CONSUMER ANALYSIS AND KEY BUYING CRITERIA
  • 2.8. COMPETITIVE ANALYSIS
    • 2.8.1. MARKET SHARE ANALYSIS & TOP COMPANY ANALYSIS
  • 2.9. STRATEGIC RECOMMENDATIONS & KEY CONCLUSIONS
    • 2.9.1. INVESTMENT OPPORTUNITIES BY REGIONS
    • 2.9.2. OPPORTUNITIES IN EMERGING APPLICATIONS
    • 2.9.3. INVESTMENT OPPORTUNITY IN FASTEST GROWING SEGMENT

3. MARKET DETERMINANTS

  • 3.1. MARKET DRIVERS
    • 3.1.1. RAPID GROWTH IN THE GERIATRIC POPULATION
    • 3.1.2. INCREASING PREFERENCE FOR MINIMALLY INVASIVE PROCEDURES
    • 3.1.3. RISING INCIDENCE OF VASCULAR DISEASES
    • 3.1.4. INNOVATIONS IN STENTING TECHNOLOGIES
  • 3.2. MARKET RESTRAINTS
    • 3.2.1. PRODUCT FAILURES AND RECALLS
    • 3.2.2. AVAILABILITY OF ALTERNATIVE TREATMENT METHODS FOR VASCULAR DISEASES
  • 3.3. MARKET OPPORTUNITIES
    • 3.3.1. DEVELOPMENT OF BIORESORBABLE STENTS
    • 3.3.2. INCREASING DEMAND FROM EMERGING MARKETS
  • 3.4. MARKET CHALLENGES
    • 3.4.1. COMPLICATIONS ASSOCIATED WITH STENT IMPLANTATION
    • 3.4.2. LACK OF AWARENESS AMONG GENERAL POPULATION

4. MARKET SEGMENTATION

  • 4.1. GLOBAL VASCULAR STENT MARKET BY TYPE
    • 4.1.1. MARKET DEFINITION AND SCOPE
    • 4.1.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
    • 4.1.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
    • 4.1.4. OPPORTUNITY MATRIX
    • 4.1.5. MARKET SEGMENTATION
      • 4.1.5.1. GLOBALDRUG-ELUTING STENTS MARKET
        • 4.1.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.1.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.1.5.1.3. KEY PLAYERS & KEY PRODUCTS
        • 4.1.5.1.4. KEY CONCLUSIONS
      • 4.1.5.2. GLOBAL BARE-METAL STENTSMARKET
        • 4.1.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.1.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.1.5.2.3. KEY PLAYERS & KEY PRODUCTS
        • 4.1.5.2.4. KEY CONCLUSIONS
      • 4.1.5.3. GLOBAL BIOABSORBABLE STENTS MARKET
        • 4.1.5.3.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.1.5.3.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.1.5.3.3. KEY PLAYERS & KEY PRODUCTS
        • 4.1.5.3.4. KEY CONCLUSIONS
  • 4.2. GLOBAL VASCULAR STENT MARKET BY PRODUCT
    • 4.2.1. MARKET DEFINITION AND SCOPE
    • 4.2.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
    • 4.2.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
    • 4.2.4. OPPORTUNITY MATRIX
    • 4.2.5. MARKET SEGMENTATION
      • 4.2.5.1. GLOBAL CORONARY STENTSMARKET
        • 4.2.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.2.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.2.5.1.3. KEY PLAYERS & KEY PRODUCTS
        • 4.2.5.1.4. KEY CONCLUSIONS
      • 4.2.5.2. GLOBALPERIPHERAL STENTSMARKET
        • 4.2.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.2.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.2.5.2.3. KEY PLAYERS & KEY PRODUCTS
        • 4.2.5.2.4. KEY CONCLUSIONS
        • 4.2.5.2.5. MARKET SUB-SEGMENTS
          • 4.2.5.2.5.1. CAROTIDARTERY STENTS
          • 4.2.5.2.5.2. RENAL ARTERY STENTS
          • 4.2.5.2.5.3. FEMORAL ARTERY STENTS
          • 4.2.5.2.5.4. OTHER STENTS
      • 4.2.5.3. GLOBALEVAR STENT GRAFTSMARKET
        • 4.2.5.3.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.2.5.3.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.2.5.3.3. KEY PLAYERS & KEY PRODUCTS
        • 4.2.5.3.4. KEY CONCLUSIONS
        • 4.2.5.3.5. MARKET SUB-SEGMENTS
          • 4.2.5.3.5.1. ABDOMINAL AORTIC ANEURYSM STENTS
          • 4.2.5.3.5.2. THORACIC AORTIC ANEURYSM STENTS
  • 4.3. GLOBAL VASCULAR STENT MARKET BY MODE OF DELIVERY
    • 4.3.1. MARKET DEFINITION AND SCOPE
    • 4.3.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
    • 4.3.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
    • 4.3.4. OPPORTUNITY MATRIX
    • 4.3.5. MARKET SEGMENTATION
      • 4.3.5.1. GLOBAL BALLOON-EXPANDABLE STENTSMARKET
        • 4.3.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.3.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.3.5.1.3. KEY PLAYERS & KEY PRODUCTS
        • 4.3.5.1.4. KEY CONCLUSIONS
      • 4.3.5.2. GLOBALSELF-EXPANDING STENTSMARKET
        • 4.3.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.3.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.3.5.2.3. KEY PLAYERS & KEY PRODUCTS
        • 4.3.5.2.4. KEY CONCLUSIONS
  • 4.4. GLOBAL VASCULAR STENT MARKET BY MATERIAL
    • 4.4.1. MARKET DEFINITION AND SCOPE
    • 4.4.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
    • 4.4.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
    • 4.4.4. OPPORTUNITY MATRIX
    • 4.4.5. MARKET SEGMENTATION
      • 4.4.5.1. GLOBAL METALLIC STENTSMARKET
        • 4.4.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.4.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.4.5.1.3. KEY PLAYERS & KEY PRODUCTS
        • 4.4.5.1.4. KEY CONCLUSIONS
        • 4.4.5.1.5. MERKET SUB-SEGMENTS
          • 4.4.5.1.5.1. COBALT CHROMIUM
          • 4.4.5.1.5.2. PLATINUM CHROMIUM
          • 4.4.5.1.5.3. NICKEL TITANIUM
          • 4.4.5.1.5.4. STAINLESS STEEL
      • 4.4.5.2. GLOBALOTHER STENTSMARKET
        • 4.4.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.4.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.4.5.2.3. KEY PLAYERS & KEY PRODUCTS
        • 4.4.5.2.4. KEY CONCLUSIONS
  • 4.5. GLOBAL VASCULAR STENT MARKET BY END USER
    • 4.5.1. MARKET DEFINITION AND SCOPE
    • 4.5.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
    • 4.5.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
    • 4.5.4. OPPORTUNITY MATRIX
    • 4.5.5. MARKET SEGMENTATION
      • 4.5.5.1. GLOBAL HOSPITALS AND CARDIAC CENTERSMARKET
        • 4.5.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.5.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.5.5.1.3. KEY PLAYERS & KEY PRODUCTS
        • 4.5.5.1.4. KEY CONCLUSIONS
      • 4.5.5.2. GLOBALAMBULATORY SURGICAL CENTERSMARKET
        • 4.5.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.5.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.5.5.2.3. KEY PLAYERS & KEY PRODUCTS
        • 4.5.5.2.4. KEY CONCLUSIONS

5. COMPETITIVE LANDSCAPE

  • 5.1. KEY STRATEGIES
    • 5.1.1. LIST OF MERGERS AND ACQUISITION
    • 5.1.2. LIST OF JOINT VENTURES
    • 5.1.3. LIST OF PRODUCT LAUNCHES
    • 5.1.4. LIST OF PARTNERSHIPS

6. GEOGRAPHIC ANALYSIS

  • 6.1. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
  • 6.2. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
  • 6.3. OPPORTUNITY MATRIX
  • 6.4. GLOBAL VASCULAR STENTMARKET BY REGION 2014-2023 ($ MILLION)
    • 6.4.1. NORTH AMERICA
      • 6.4.1.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
      • 6.4.1.2. TOP COUNTRY ANALYSIS
        • 6.4.1.2.1. U.S.
          • 6.4.1.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.1.2.1.2. KEY PLAYERS & KEY PRODUCTS
          • 6.4.1.2.1.3. KEY CONCLUSIONS
        • 6.4.1.2.2. CANADA
          • 6.4.1.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.1.2.2.2. KEY PLAYERS & KEY PRODUCTS
          • 6.4.1.2.2.3. KEY CONCLUSIONS
    • 6.4.2. EUROPE
      • 6.4.2.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
      • 6.4.2.2. TOP COUNTRY ANALYSIS
        • 6.4.2.2.1. UK
          • 6.4.2.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.2.2.1.2. KEY PLAYERS & KEY PRODUCTS
          • 6.4.2.2.1.3. KEY CONCLUSIONS
        • 6.4.2.2.2. FRANCE
          • 6.4.2.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.2.2.2.2. KEY PLAYERS & KEY PRODUCTS
          • 6.4.2.2.2.3. KEY CONCLUSIONS
        • 6.4.2.2.3. GERMANY
          • 6.4.2.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.2.2.3.2. KEY PLAYERS & KEY PRODUCTS
          • 6.4.2.2.3.3. KEY CONCLUSIONS
        • 6.4.2.2.4. SPAIN
          • 6.4.2.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.2.2.4.2. KEY PLAYERS & KEY PRODUCTS
          • 6.4.2.2.4.3. KEY CONCLUSIONS
        • 6.4.2.2.5. REST OF EUROPE
          • 6.4.2.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.2.2.5.2. KEY PLAYERS & KEY PRODUCTS
          • 6.4.2.2.5.3. KEY CONCLUSIONS
    • 6.4.3. ASIA PACIFIC
      • 6.4.3.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
      • 6.4.3.2. TOP COUNTRY ANALYSIS
        • 6.4.3.2.1. CHINA
          • 6.4.3.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.3.2.1.2. KEY PLAYERS & KEY PRODUCTS
          • 6.4.3.2.1.3. KEY CONCLUSIONS
        • 6.4.3.2.2. INDIA
          • 6.4.3.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.3.2.2.2. KEY PLAYERS & KEY PRODUCTS
          • 6.4.3.2.2.3. KEY CONCLUSIONS
        • 6.4.3.2.3. JAPAN
          • 6.4.3.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.3.2.3.2. KEY PLAYERS & KEY PRODUCTS
          • 6.4.3.2.3.3. KEY CONCLUSIONS
        • 6.4.3.2.4. AUSTRALIA
          • 6.4.3.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.3.2.4.2. KEY PLAYERS & KEY PRODUCTS
          • 6.4.3.2.4.3. KEY CONCLUSIONS
        • 6.4.3.2.5. REST OF ASIA PACIFIC
          • 6.4.3.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.3.2.5.2. KEY PLAYERS & KEY PRODUCTS
          • 6.4.3.2.5.3. KEY CONCLUSIONS
    • 6.4.4. ROW
      • 6.4.4.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
      • 6.4.4.2. TOP COUNTRY ANALYSIS
        • 6.4.4.2.1. LATIN AMERICA
          • 6.4.4.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.4.2.1.2. KEY PLAYERS & KEY PRODUCTS
          • 6.4.4.2.1.3. KEY CONCLUSIONS
        • 6.4.4.2.2. MIDDLE EAST & AFRICA
          • 6.4.4.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.4.2.2.2. KEY PLAYERS & KEY PRODUCTS
          • 6.4.4.2.2.3. KEY CONCLUSIONS

7. COMPANY PROFILES

  • 7.1. ABBOTT LABORATORIES (U.S.)
    • 7.1.1. OVERVIEW
    • 7.1.2. PRODUCT PORTFOLIO
    • 7.1.3. STRATEGIC INITIATIVES
    • 7.1.4. SCOT ANALYSIS
    • 7.1.5. STRATEGIC ANALYSIS
  • 7.2. B. BRAUN MELSUNGEN AG (GERMANY)
    • 7.2.1. OVERVIEW
    • 7.2.2. PRODUCT PORTFOLIO
    • 7.2.3. STRATEGIC INITIATIVES
    • 7.2.4. SCOT ANALYSIS
    • 7.2.5. STRATEGIC ANALYSIS
  • 7.3. BIOTRONIK SE & CO. KG (GERMANY)
    • 7.3.1. OVERVIEW
    • 7.3.2. PRODUCT PORTFOLIO
    • 7.3.3. STRATEGIC INITIATIVES
    • 7.3.4. SCOT ANALYSIS
    • 7.3.5. STRATEGIC ANALYSIS
  • 7.4. BOSTON SCIENTIFIC CORPORATION (U.S)
    • 7.4.1. OVERVIEW
    • 7.4.2. PRODUCT PORTFOLIO
    • 7.4.3. STRATEGIC INITIATIVES
    • 7.4.4. SCOT ANALYSIS
    • 7.4.5. STRATEGIC ANALYSIS
  • 7.5. C.R. BARD, INC. (U.S.)
    • 7.5.1. OVERVIEW
    • 7.5.2. PRODUCT PORTFOLIO
    • 7.5.3. STRATEGIC INITIATIVES
    • 7.5.4. SCOT ANALYSIS
    • 7.5.5. STRATEGIC ANALYSIS
  • 7.6. CORDIS CORPORATION (U.S.)
    • 7.6.1. OVERVIEW
    • 7.6.2. PRODUCT PORTFOLIO
    • 7.6.3. STRATEGIC INITIATIVES
    • 7.6.4. SCOT ANALYSIS
    • 7.6.5. STRATEGIC ANALYSIS
  • 7.7. ENDOLOGIX, INC. (U.S.)
    • 7.7.1. OVERVIEW
    • 7.7.2. PRODUCT PORTFOLIO
    • 7.7.3. STRATEGIC INITIATIVES
    • 7.7.4. SCOT ANALYSIS
    • 7.7.5. STRATEGIC ANALYSIS

7.7.6.

  • 7.8. LOMBARD MEDICAL (U.K.)
    • 7.8.1. OVERVIEW
    • 7.8.2. PRODUCT PORTFOLIO
    • 7.8.3. STRATEGIC INITIATIVES
    • 7.8.4. SCOT ANALYSIS
    • 7.8.5. STRATEGIC ANALYSIS
  • 7.9. MEDTRONIC PLC (U.S.)
    • 7.9.1. OVERVIEW
    • 7.9.2. PRODUCT PORTFOLIO
    • 7.9.3. STRATEGIC INITIATIVES
    • 7.9.4. SCOT ANALYSIS
    • 7.9.5. STRATEGIC ANALYSIS
  • 7.10. MERIL LIFE SCIENCES PVT. LTD. (INDIA)
    • 7.10.1. OVERVIEW
    • 7.10.2. PRODUCT PORTFOLIO
    • 7.10.3. STRATEGIC INITIATIVES
    • 7.10.4. SCOT ANALYSIS
    • 7.10.5. STRATEGIC ANALYSIS
  • 7.11. MICROPORT SCIENTIFIC CORPORATION (CHINA)
    • 7.11.1. OVERVIEW
    • 7.11.2. PRODUCT PORTFOLIO
    • 7.11.3. STRATEGIC INITIATIVES
    • 7.11.4. SCOT ANALYSIS
    • 7.11.5. STRATEGIC ANALYSIS
  • 7.12. TERUMO CORPORATION (JAPAN)
    • 7.12.1. OVERVIEW
    • 7.12.2. PRODUCT PORTFOLIO
    • 7.12.3. STRATEGIC INITIATIVES
    • 7.12.4. SCOT ANALYSIS
    • 7.12.5. STRATEGIC ANALYSIS
  • 7.13. TRANSLUMINA GMBH (GERMANY)
    • 7.13.1. OVERVIEW
    • 7.13.2. PRODUCT PORTFOLIO
    • 7.13.3. STRATEGIC INITIATIVES
    • 7.13.4. SCOT ANALYSIS
    • 7.13.5. STRATEGIC ANALYSIS
  • 7.14. VASCULAR CONCEPTS LIMITED (INDIA)
    • 7.14.1. OVERVIEW
    • 7.14.2. PRODUCT PORTFOLIO
    • 7.14.3. STRATEGIC INITIATIVES
    • 7.14.4. SCOT ANALYSIS
    • 7.14.5. STRATEGIC ANALYSIS
  • 7.15. W.L. GORE AND ASSOCIATES, INC. (U.S.)
    • 7.15.1. OVERVIEW
    • 7.15.2. PRODUCT PORTFOLIO
    • 7.15.3. STRATEGIC INITIATIVES
    • 7.15.4. SCOT ANALYSIS
    • 7.15.5. STRATEGIC ANALYSIS

LIST OF TABLES

  • 1. GLOBAL VASCULAR STENT MARKET BY TYPE2014-2023 ($ MILLION)
  • 2. GLOBAL DRUG-ELUTING STENTSMARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 3. GLOBAL BARE-METAL STENTS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 4. GLOBAL BIOABSORBABLE STENTS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 5. GLOBAL VASCULAR STENT MARKET BY PRODUCT 2014-2023 ($ MILLION)
  • 6. GLOBALCORONARY STENTS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 7. GLOBAL PERIPHERAL STENTS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 8. GLOBAL VASCULAR STENT MARKET BYPERIPHERAL STENTS2014-2023 ($ MILLION)
  • 9. GLOBAL EVAR STENT GRAFTSMARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 10. GLOBAL VASCULAR STENT MARKET BYEVAR STENT GRAFTS2014-2023 ($ MILLION)
  • 11. GLOBAL VASCULAR STENT MARKET BY MODE OF DELIVERY2014-2023 ($ MILLION)
  • 12. GLOBAL BALLOON-EXPANDABLE STENTSMARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 13. GLOBAL SELF-EXPANDING STENTSMARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 14. GLOBAL VASCULAR STENT MARKET BYMATERIAL2014-2023 ($ MILLION)
  • 15. GLOBAL METALLIC STENTSMARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 16. GLOBAL VASCULAR STENT MARKET BYMETALLIC STENTS2014-2023 ($ MILLION)
  • 17. GLOBAL OTHER STENTSMARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 18. GLOBAL VASCULAR STENT MARKET BY END USER 2014-2023 ($ MILLION)
  • 19. GLOBAL HOSPITALS AND CARDIAC CENTERSMARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 20. GLOBAL AMBULATORY SURGICAL CENTERSMARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 21. NORTH AMERICA VASCULAR STENT MARKET 2014-2023 ($ MILLION)
  • 22. EUROPE VASCULAR STENT MARKET 2014-2023 ($ MILLION)
  • 23. ASIA PACIFIC VASCULAR STENT MARKET 2014-2023 ($ MILLION)
  • 24. REST OF THE WORLD VASCULAR STENT MARKET 2014-2023 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL VASCULAR STENT MARKET BY TYPE2014-2023 ($ MILLION)
  • 2. GLOBAL DRUG-ELUTING STENTSMARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 3. GLOBAL BARE-METAL STENTS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 4. GLOBAL BIOABSORBABLE STENTS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 5. GLOBAL VASCULAR STENT MARKET BY PRODUCT 2014-2023 ($ MILLION)
  • 6. GLOBALCORONARY STENTS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 7. GLOBAL PERIPHERAL STENTS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 8. GLOBAL CAROTID ARTERY STENTSMARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 9. GLOBAL RENAL ARTERY STENTSMARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 10. GLOBAL FEMORAL ARTERY STENTSMARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 11. GLOBAL OTHER STENTSMARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 12. GLOBAL EVAR STENT GRAFTSMARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 13. GLOBAL ABDOMINAL AORTIC ANEURYSM STENTSMARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 14. GLOBAL THORACIC AORTIC ANEURYSM STENTSMARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 15. GLOBAL VASCULAR STENT MARKET BY MODE OF DELIVERY2014-2023 ($ MILLION)
  • 16. GLOBAL BALLOON-EXPANDABLE STENTSMARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 17. GLOBAL SELF-EXPANDING STENTSMARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 18. GLOBAL VASCULAR STENT MARKET BYMATERIAL2014-2023 ($ MILLION)
  • 19. GLOBAL METALLIC STENTSMARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 20. GLOBAL COBALT CHROMIUMMARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 21. GLOBAL PLATINUM CHROMIUMMARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 22. GLOBAL NICKEL TITANIUMMARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 23. GLOBAL STAINLESS STEELMARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 24. GLOBAL OTHER STENTSMARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 25. GLOBAL VASCULAR STENT MARKET BY END USER 2014-2023 ($ MILLION)
  • 26. GLOBAL HOSPITALS AND CARDIAC CENTERSMARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 20. GLOBAL AMBULATORY SURGICAL CENTERSMARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 21. UNITED STATES (U.S.) VASCULAR STENT MARKET 2014-2023 ($ MILLION)
  • 22. CANADA VASCULAR STENT MARKET 2014-2023 ($ MILLION)
  • 23. UNITED KINGDOM (UK) VASCULAR STENT MARKET 2014-2023 ($ MILLION)
  • 24. FRANCE VASCULAR STENT MARKET 2014-2023 ($ MILLION)
  • 25. GERMANY VASCULAR STENT MARKET 2014-2023 ($ MILLION)
  • 26. SPAIN VASCULAR STENT MARKET 2014-2023 ($ MILLION)
  • 27. ROE VASCULAR STENT MARKET 2014-2023 ($ MILLION)
  • 28. INDIA VASCULAR STENT MARKET 2014-2023 ($ MILLION)
  • 29. CHINA VASCULAR STENT MARKET 2014-2023 ($ MILLION)
  • 30. JAPAN VASCULAR STENT MARKET 2014-2023 ($ MILLION)
  • 31. AUSTRALIA VASCULAR STENT MARKET 2014-2023 ($ MILLION)
  • 32. ROAPAC VASCULAR STENT MARKET 2014-2023 ($ MILLION)
  • 33. LATIN AMERICA VASCULAR STENT MARKET 2014-2023 ($ MILLION)
  • 34. MENA VASCULAR STENT MARKET 2014-2023 ($ MILLION)
Back to Top